[HTML][HTML] Advance in targeted immunotherapy for graft-versus-host disease

L Zhang, J Yu, W Wei - Frontiers in immunology, 2018 - frontiersin.org
Graft-versus-host disease (GVHD) is a serious and deadly complication of patients, who
undergo hematopoietic stem cell transplantation (HSCT). Despite prophylactic treatment …

Current and emerging targeted therapies for acute graft-Versus-Host disease

S Kasikis, A Etra, JE Levine - BioDrugs, 2021 - Springer
Acute graft-versus-host disease (GVHD), the major complication after allogeneic
hematopoietic cell transplant (HCT), develops in approximately 50% of patients. The primary …

Recent advances in the management of graft-versus-host disease

S Dhir, M Slatter, R Skinner - Archives of disease in childhood, 2014 - adc.bmj.com
Graft-versus-host disease (GvHD) remains a significant hurdle in overcoming the morbidity
and mortality associated with haemopoietic stem cell transplantation in children. Better …

[HTML][HTML] Treatment of steroid-refractory graft versus host disease in children

F Gottardi, D Leardini, E Muratore, F Baccelli… - Frontiers in …, 2023 - frontiersin.org
Systemic steroids are still the first-line approach in acute graft-versus-host disease (aGvHD),
and the backbone of chronic GvHD management. Refractoriness to steroid represent a …

调节性T 细胞/T 效应细胞免疫平衡在急性移植物抗宿主病中的研究进展

陈天平, 金玉莲, 汪俭, 屈丽君 - 国际免疫学杂志, 2015 - cqvip.com
CD4+ CD25+ Foxp3+ 调节性T 细胞(Treg) 维持机体免疫平衡, 介导免疫耐受, CD4+ CD25+ T
效应细胞(Teff) 介导前炎症反应. 两者是两类不同的CD4+ T 淋巴细胞亚群, 在功能上相互拮抗 …

[图书][B] Complicaciones del trasplante alogénico de progenitores hematopoyéticos: enfermedad de injerto contra el receptor y predisposición a infecciones: estrategias …

I Garcia Cadenas - 2017 - ddd.uab.cat
El trasplante alogénico de progenitores hematopoyéticos (alo-TPH) representa la única
estrategia curativa para un grupo no desdeñable de enfermedades hematológicas …

[HTML][HTML] Экстракорпоральный фотоферез и антицитокиновая терапия в лечении стероид-рефрактерной острой реакции «Трансплантат против хозяина» …

АВ Козлов, ЮГ Федюкова, ТА Быкова, ИС Моисеев… - Педиатр, 2016 - cyberleninka.ru
Аллогенная трансплантация гемопоэтических стволовых клеток (алло-ТГСК) широко
применятся для лечения детей с гематологическими, онкологическими и …

Basiliximab (Simulect®) and Daclizumab (Zenapax®)

N Mahmud, B Taner, N Ahsan - Handbook of Therapeutic …, 2014 - Wiley Online Library
To function as effector cells, T cells must undergo antigen‐stimulated activation that induces
synthesis of many lymphokines, including interleukin‐2 (IL‐2). In certain diseases, a …

Extracorporeal photopheresis and anticytokine therapy in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell …

AV Kozlov, JG Fedukova, TA Bykova… - Pediatrician (St …, 2016 - journals.eco-vector.com
Allogeneic hematopoietic stem cell transplantation (allo-SCT) is used widely in the
management of children with hematological, oncological and inherited diseases. Study to …